managing colorectal cancer in patients who progress on regorafenib
Published 4 months ago • 51 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
2:01
dr. holcombe on the progress of colorectal cancer and regorafenib
-
2:52
metastatic colorectal cancer: trifluridine/tiripacil or regorafenib?
-
2:36
prognostic value of metastatic sites in patients with mcrc treated with regorafenib
-
![regorafenib in management of colorectal cancer – video abstract [id 88825]](https://i.ytimg.com/vi/ZMhWfX9j594/mqdefault.jpg)
7:41
regorafenib in management of colorectal cancer – video abstract [id 88825]
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
8:47
colorectal cancer: dosing strategies with regorafenib
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
3:10
regorafenib in refractory biliary tract cancer
-
5:32
colorectal cancer: regorafenib patient selection and dosing
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc
-
8:26
regorafenib in advanced colorectal cancer: dosing strategies
-
4:47
regorafenib nivolumab in mmr proficient advanced crc
-
9:34
regorafenib in colorectal cancer
-
6:56
prior rt may potentially enhance treatment of mss-crc with regorafenib and pembrolizumab
-
1:11
soregatt: sequencing regorafenib & trifluridine/tipiracil in pre-treated mcrc
-
1:25
treating crc with regorafenib in latin america
-
1:23
the rationale for combining regorafenib with io to treat patients with refractory mss-crc
-
11:24
managing toxicities associated with regorafenib